Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining why ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

An obvious next step in the development and growth of CAR T-cell therapies has been the jump to solid tumors. Because of ...

Hematology blood disorders are diseases that affect the blood and hematopoietic system’s functions. It includes leukemia, ...

Roche will acquire Poseida Therapeutics, building on a partnership for CAR T-cell therapies in development for MS and other ...

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...

A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine.